September 29, 2014

Baxter to Form New Global Innovation and R&D Center Near Boston for its Biopharmaceuticals Business

DEERFIELD, Ill., September 29, 2014 – Baxter International Inc. (NYSE:BAX) today announced plans to form a new global innovation and research and development (R&D) center in Cambridge, Mass., for Baxter’s biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta Incorporated in mid-2015.

Read the press release here »

September 29, 2014

State and Industry Officials Commend Baxter on Plans to Locate Global Innovation and R&D Center in Cambridge, Massachusetts

Cambridge, MA, September 29, 2014 –Governor Deval Patrick and Massachusetts life sciences leaders from government and industry today commended Baxter for their decision to locate 400 jobs at a new Global Innovation and R&D Center in Cambridge, Massachusetts. The new facility, eventually slated to reach 200,000 square feet, will begin operations later this year.

Read the press release here »

September 24, 2014

Harvard Medical School Opens Laboratory of Systems Pharmacology

Harvard Medical School opened its new Laboratory of Systems Pharmacology, an innovative new endeavor aimed at reinventing the fundamental science underlying drug development, located on Longwood Avenue in Boston. Harvard Medical School Dean Jeff Flier, along with Director of the Laboratory of Systems Pharmacology Peter Sorger, President & CEO of the Massachusetts Life Sciences Center Susan Windham-Bannister, Ph.D., and the Chair of the facility’s Oversight Committee, Joshua Boger were among those attending the ribbon cutting ceremony. Construction of the new research facility was funded through a $5 million grant from the Massachusetts Life Sciences Center (MLSC).

(Left to right) Co-Chair of the Advisory Council for the Harvard Program in Therapeutic Science Joshua Boger; President & CEO of the Massachusetts Life Sciences Susan Windham-Bannister; Dean of Harvard Medical School Jeffrey Flier; Executive Director of the Harvard Program in Therapeutic Science Laura Maliszewski, and Director of the Laboratory of Systems Pharmacology Peter Sorger celebrate the opening of Harvard Medical School’s new Laboratory for Systems Pharmacology.

(Left to right) Co-Chair of the Advisory Council for the Harvard Program in Therapeutic Science Joshua Boger; President & CEO of the Massachusetts Life Sciences Susan Windham-Bannister; Dean of Harvard Medical School Jeffrey Flier; Executive Director of the Harvard Program in Therapeutic Science Laura Maliszewski, and Director of the Laboratory of Systems Pharmacology Peter Sorger celebrate the opening of Harvard Medical School’s new Laboratory for Systems Pharmacology.

 

Read the press release here »

September 22, 2014

Sobi Opens North American Operations

Waltham – Monday, September 22, 2014Swedish Orphan Biovitrum AB (publ) (Sobi) today formally opened the Company’s new North American Head Office in Waltham, Massachusetts with a ribbon cutting ceremony arranged in collaboration with the Massachusetts Life Sciences Center (MLSC).

Read the press release here »

September 18, 2014

Life Sciences Delegation Meets with French Life Sciences Business Leaders to Discuss Collaboration

Massachusetts Life Sciences Center President & CEO Susan Windham-Bannister, Ph.D., today met with Life Sciences executives from the Lyon region of France to discuss what Massachusetts has to offer for growing companies in the life sciences industry. Massachusetts has become the leading destination for international life sciences companies that are looking to enter or expand their presence in the U.S. Market, including companies from France.

Read the press release here »

September 15, 2014

Governor Patrick Leads Life Sciences Innovation Partnership Forum in Denmark

As a follow-up to signing a Memorandum of Understanding (MOU) between Massachusetts and Medicon Valley in 2012, Governor Deval Patrick today spoke at a Life Sciences Innovation Partnership Forum in Copenhagen. The forum was part of the Governor’s innovation partnership mission to Denmark, the United Kingdom and France to expand opportunities between the Commonwealth and these three European countries for economic development and job creation in the innovation economy, clean tech, digital gaming, financial services, workforce training and education sectors.

Read the press release here »

September 3, 2014

MediSapiens Continues to Grow its U.S. Operations

CAMBRIDGE, MA – September 3, 2014 – MediSapiens Inc., a subsidiary of a Finland-based bioinformatics company announced today that it is ramping up its operations in the U.S. and moving to new offices in the Cambridge Innovation Center (CIC) in Kendall Square. After being incorporated in the U.S. at the end of 2013, the U.S. arm of MediSapiens is now fully launching its operations in Massachusetts, including the newly hired employees that began working this summer.

Read the press release here »

August 20, 2014

GE Healthcare Life Sciences to Create New U.S. Headquarters in Massachusetts

  • When fully operational, new facility will house  more than 500 highly skilled employees and  bring more than 220 new jobs to Massachusetts
  • Long-term investment places new US business headquarters at the heart of the most dynamic and growing life sciences, healthcare and biotech cluster in the US
  • Furthers GE Healthcare Life Sciences’ leadership in molecular and precision medicine, clinical diagnostics, manufacturing and R&D
August 12, 2014

EMD Serono, Inc. Opens New Building in Billerica, Massachusetts

EMD Serono, Inc., an affiliate of Merck KGaA, announced the official site opening of their new Sagamore Building in Billerica, Massachusetts, and the dedication of the Bridge to Patients.  The Sagamore Building is a renovated facility designed to foster exploration and creativity, improve interactions between colleagues and enable a culture of possibilities. EMD Serono, Inc. and Merck KGaA executives, directors and employees celebrated the announcement at a ribbon-cutting ceremony with government officials from Massachusetts, and leaders of the Massachusetts life sciences industry.

Final - 2

Susan Windham-Bannister, Ph.D. President & CEO of the Massachusetts Life Sciences Center; John Tierney, U.S. Representative, 6th District of Massachusetts; Frank Stangenberg-Haverkamp, Ph.D. Merck family member and Chairman Executive Board of E. Merck KG; Paris Panayiotopoulos, President and Marketing Director, EMD Serono; Luciano Rossetti, MD. Executive Vice President, Global Head of Research & Development, Merck Serono; and Robert K. Coughlin, President & CEO of MassBio celebrate the dedication of EMD Serono’s new Sagamore Building and Bridge to Patients in Billerica.

August 5, 2014

Andrew Alliance Secures Series B Financing to Boost Growth of Life Science Co-worker Robot

Andrew Alliance announced today that the Company will be opening up a Boston office in Copley Square. The Company also announced the closing of a series B financing round from Omega Funds, a leading global healthcare fund specializing in late stage life science investments. The Omega investment will enable Andrew Alliance to expand the reach of its well-received robots, by enabling new developments and the establishment of commercial operations in the U.S. market.

Read the press release here »

July 28, 2014

Massachusetts Life Sciences Center Announces 2014 – 2015 Solicitation for Capital Projects

The Massachusetts Life Sciences Center (MLSC) announced today the launch of the fourth round of an open solicitation for life-sciences-related capital projects. The solicitation covers capital projects for academic/research institutions (including two- and four-year colleges), business incubators and other not-for-profit organizations in the Commonwealth. The MLSC will invest in high-potential economic development projects across the state that promise to create jobs and make a significant contribution to the state’s life sciences ecosystem. The MLSC has allocated up to $35 million in capital dollars for this solicitation.

Read the press release here »

July 22, 2014

Massachusetts Life Sciences Center Announces Opening of 2014 Life Sciences Tax Incentive Program

The Massachusetts Life Sciences Center announced today that applications are now being accepted for the 2014 Life Sciences Tax Incentive Program. All applications are due by 12:00 p.m. ET on Thursday, October 23, 2014 and can be submitted online.

The Program offers tax incentives to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. The Life Sciences Initiative authorizes the Center to award up to $25 million in tax incentives each year. Through five prior rounds the Center has awarded more than $115 million to growing companies across the state that have created thousands of jobs as a result.

To learn more about the program, register for information sessions, or apply, click here

Read the press release here »

July 15, 2014

Massachusetts Life Sciences Center Welcomes New Member to Corporate Consortium

The Massachusetts Life Sciences Center (MLSC) announced today that Roche has joined the Center’s Corporate Consortium Program, contributing funding to support MLSC investments in promising early stage companies.

Under the newly announced partnership, Roche, via their “Extending the Innovation Network” program aimed at discovering and creating opportunities in academia and biotech, will contribute funds to help support Massachusetts’ commitment to grow and retain early-stage life sciences companies.

Read the press release here »

July 14, 2014

A Request for Proposal for an Executive Search Firm has been Released by the MLSC

The Massachusetts Life Sciences Center has released a Request for Proposal (RFP) for an Executive Search Firm to recruit candidates for the position of President and Chief Executive Officer of the Center.

To access the RFP, please click here.

To access the Answers to Questions, please click here.

July 9, 2014

2011 MLSC Accelerator Company AesRx Repays Loan Early After Acquisition

The Massachusetts Life Sciences Center (MLSC) announced today that Newton-based AesRx, an Accelerator company awarded $750,000 in loan financing by the MLSC in 2011, has paid back its loan early after being acquired by Baxter International Inc., a diversified healthcare company based in Deerfield, IL. The company’s repayment amount (including investment proceeds) totaled $1,024,000. The acquisition was announced today in press releases issued by Baxter and the National Institutes of Health.

Read the press release here »

Connect With Us

Facebook LinkedIn Twitter